Literature DB >> 33740245

Lipid Metabolism in Tumor-Associated Macrophages.

Yuancai Xiang1, Hongming Miao2.   

Abstract

Macrophages are essential components of the immune system in tumors. It can be recruited and educated to two mainly polarized subpopulations (M1-like and M2-like) of tumor-associated macrophages (TAMs) to display anti-tumor or protumor function during the tumor occurrence and progression. Reprogramming of metabolism, especially lipid metabolism, is a typical characteristic of TAMs polarization, which was confirmed recently as a vital target for tumor therapy. However, the relationship between TAMs and lipid metabolism is still obscure in the past decade. In this review, we will first introduce the historical aspects of TAMs, and then discuss the correlation of main lipids (triglycerides, cholesterol, and phospholipids) to TAMs activation and summarize the mechanisms by which lipid metabolism mediated tumor escape the immunological surveillance as well as currently available drugs targeting these mechanisms. We hope that this chapter will give a better understanding of lipid metabolism in TAMs for those who are interested in this field, and lay a foundation to develop novel strategies for tumor therapy by targeting lipid metabolism.

Entities:  

Keywords:  Lipid metabolism; Macrophage polarization; Tumor therapy; Tumor-associated macrophages

Mesh:

Year:  2021        PMID: 33740245     DOI: 10.1007/978-981-33-6785-2_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  93 in total

Review 1.  The origin and function of tumor-associated macrophages.

Authors:  A Mantovani; B Bottazzi; F Colotta; S Sozzani; L Ruco
Journal:  Immunol Today       Date:  1992-07

Review 2.  A close encounter of the third kind: monocyte-derived cells.

Authors:  Alexander Mildner; Simon Yona; Steffen Jung
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

Review 3.  Macrophages: A review of their role in wound healing and their therapeutic use.

Authors:  Robert J Snyder; John Lantis; Robert S Kirsner; Vivek Shah; Michael Molyneaux; Marissa J Carter
Journal:  Wound Repair Regen       Date:  2016-06-14       Impact factor: 3.617

4.  M1 Means Kill; M2 Means Heal.

Authors:  Klaus Ley
Journal:  J Immunol       Date:  2017-10-01       Impact factor: 5.422

5.  Tumor microenvironment profoundly modifies functional status of macrophages: peritoneal and tumor-associated macrophages are two very different subpopulations.

Authors:  Dayron Rodríguez; Risset Silvera; Roberto Carrio; Mehrdad Nadji; Raul Caso; Gracielena Rodríguez; Vijaya Iragavarapu-Charyulu; Marta Torroella-Kouri
Journal:  Cell Immunol       Date:  2013-06-19       Impact factor: 4.868

Review 6.  Macrophages and tissue injury: agents of defense or destruction?

Authors:  Debra L Laskin; Vasanthi R Sunil; Carol R Gardner; Jeffrey D Laskin
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

Review 7.  Human mononuclear phagocyte system reunited.

Authors:  Muzlifah Haniffa; Venetia Bigley; Matthew Collin
Journal:  Semin Cell Dev Biol       Date:  2015-05-15       Impact factor: 7.727

Review 8.  From the Reticuloendothelial to Mononuclear Phagocyte System - The Unaccounted Years.

Authors:  Simon Yona; Siamon Gordon
Journal:  Front Immunol       Date:  2015-07-01       Impact factor: 7.561

Review 9.  Tumor-Associated Macrophages: Recent Insights and Therapies.

Authors:  Jiawei Zhou; Ziwei Tang; Siyang Gao; Chunyu Li; Yiting Feng; Xikun Zhou
Journal:  Front Oncol       Date:  2020-02-25       Impact factor: 6.244

10.  The origin and kinetics of mononuclear phagocytes.

Authors:  R van Furth; Z A Cohn
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307

View more
  5 in total

1.  Identification of solute-carrier family 27A molecules (SCL27As) as a potential biomarker of ovarian cancer based on bioinformatics and experiments.

Authors:  Hao Chen; Tao Han; Yi Zhao; Liang Feng
Journal:  Ann Transl Med       Date:  2021-08

2.  Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.

Authors:  Jing He; Ziwei Chen; Qingfeng Xue; Pingping Sun; Yuan Wang; Cindy Zhu; Wenyu Shi
Journal:  J Transl Med       Date:  2022-04-25       Impact factor: 8.440

Review 3.  Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma.

Authors:  Abudureyimu Tuerhong; Jin Xu; Si Shi; Zhen Tan; Qingcai Meng; Jie Hua; Jiang Liu; Bo Zhang; Wei Wang; Xianjun Yu; Chen Liang
Journal:  Cell Mol Life Sci       Date:  2021-06-15       Impact factor: 9.261

Review 4.  Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review.

Authors:  Meng-Ying Cui; Xing Yi; Zhen-Zhen Cao; Dan-Xia Zhu; Jun Wu
Journal:  J Oncol       Date:  2022-09-05       Impact factor: 4.501

5.  A Novel Risk Model Based on Lipid Metabolism-Associated Genes Predicts Prognosis and Indicates Immune Microenvironment in Breast Cancer.

Authors:  Zhimin Ye; Shengmei Zou; Zhiyuan Niu; Zhijie Xu; Yongbin Hu
Journal:  Front Cell Dev Biol       Date:  2021-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.